Part of Phaidon International
Part of Phaidon International
Showing 670 results
Sort by:
Head of CMC (VP/SVP) & Technical OperationsLocation: MarylandBase Salary: $300,000-$450,000 + Executive Incentive PackageSUMMARYEPM Scientific is exclusively partnering with a clinical-stage biotech in the Maryland to identify a Head of CMC & Technical Operations during an important period of organizational and pipeline growth.This individual will ...
Scientific DirectorUSA Based (Remote or Hybrid in NYC)Join a growing, established medical communications team supporting pharmaceutical and biotechnology clients through the development of high-impact scientific content and strategic communications initiatives. This position combines scientific leadership, client partnership, mentoring, and busines...
Medical WriterUSA Based (Remote or Hybrid in NYC)Exciting opportunity to join a well-known, established medical communications agency! Our long-term client is looking for someone with 1+ years of experience to join their promotional med ed/medical affairs team. Key ResponsibilitiesDevelop scientifically accurate content across a range of medical c...
Take the first step toward your next opportunity - submit your resume and get started today.
QC Senior Scientist, Raw Materials Portsmouth, NH (Onsite)We're partnering with a leading life sciences manufacturing organization that is looking to add a QC Senior Scientist to support raw materials testing and laboratory operations at its Portsmouth, NH site.This is a great opportunity for a scientist who enjoys solving technical challenges, wor...
SVP, Healthcare Media Business Unit Lead EPM Scientific is partnered with an established healthcare media and education organization investing in two new commercial businesses: a programmatic HCP media offering and a healthcare data products business. The organization is seeking an entrepreneurial senior leader to refine the strategy, build the ini...
The OpportunityThis is a rare chance to step in as the in‑region clinical operations lead for APAC at a privately backed, clinical‑stage biotech entering a decisive phase of growth. The company has moved beyond platform promise into execution - multiple programs advancing, real patients enrolling, and global timelines that now depend on strong regi...